Trial intelligence / Profile preview

Dose-finding study of intravitreal fluocinolone acetonide inserts for diabetic macular edema

2006-001035-22Phase 3Completed

Sponsor
Alimera Sciences
Start
Mar 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluocinolone in diabetic macular edema (DME), sponsored by Alimera Sciences. Started Mar 2006; status: completed.

02

Drugs

fluocinolone
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on 2006-001035-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001035-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call